1. Home
  2. News
  3. NATCO Pharma Limited
  4. Press Release Sep 24 2022
More NATCO Pharma Limited news
NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Sep 24 2022

Sep 24, 2022 at 12:43 PM EDT · Issued by NATCO Pharma Limited

Filed with NSE · Sep 24, 2022 at 12:43 PM EDT · 2 pages · English

Summary by 6ix AI

NATCO Pharma Limited has issued a press release regarding the launch of a new product.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/press-release-sep-24-2022-2

Watch NATCO Pharma's latest callNATCO Pharma (NSE:NATCOPHARM) Q2 2027 Earnings Call · Replay · Nov 13↗

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

  • Press Release Sep 19 2022Sep 19, 2022
  • Press Release Aug 17 2022Aug 17, 2022
  • NATCO records INR 918.9 Crore consolidated revenue and INR 320.4 Crore of profit, after tax, for the First Quarter, FY2022-23Aug 10, 2022
  • Press Release Jul 25 2022Jul 25, 2022
  • NATCO Announces Launch of First Generic Version of Nexavar (Sorafenib) Tablets in the U.S. MarketJun 2, 2022

Later from NATCO Pharma

  • Press Release Oct 04 2022Oct 4, 2022
  • Press Release Oct 21 2022Oct 21, 2022
  • Press Release Nov 09 2022Nov 9, 2022
  • Press Release Nov 12 2022Nov 12, 2022
  • Press Release Nov 16 2022Nov 16, 2022
All NATCO Pharma news releases↗

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer